J&J's Trem­fya fails gi­ant cell ar­teri­tis study, where Roche and Ab­b­Vie have suc­ceed­ed

John­son & John­son’s streak of tri­al wins for its block­buster drug Trem­fya has come to an end.

The block­buster drug failed in a Phase 2 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.